Building Trust in Real-World Evidence With AI and High-Quality Data
Aug 11, 2026 - 00:14:13
Radio and PodcastLive Radio & Podcasts
Science & Medicine
HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! The FDA’s recent expanded approval of zongertinib marks a significant milestone in the tre...
Related Episodes
Continue listening to more episodes from Oncology Data Advisor.
One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Aug 10, 2026 - 00:20:06
Advancing Extrapulmonary NEC: DLL3 & Beyond
Jul 30, 2026 - 00:56:05
Prostate Cancer Breakthroughs: TALAPRO-3, PROTEUS, & Earlier Therapy
Jul 28, 2026 - 00:13:59
Advances in CIDP: Consensus Definitions, Emerging Pipeline & Individualized Care
Jul 28, 2026 - 00:05:23
Information Overload and the Portal Patient: The Era of Instant Test Results
Jul 9, 2026 - 00:18:01
One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Jul 1, 2026 - 00:20:06